Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives. Its vision is to use its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.

Biotechnology

Therapeutics

Vicinitas Therapeutics

Christian Hofmann

Daniel Nomura

The Leadership Team at Vicinitas Therapeutics oversees the strategic direction and scientific advancements of the company. They leverage their expertise to guide the development of the DUBTAC platform, secure partnerships, and drive the mission of restoring protein levels to treat diseases.

Leadership Team

About

Team members

Other teams at Vicinitas Therapeutics

Scientific Research Team